Current Report Filing (8-k)
January 17 2020 - 4:00PM
Edgar (US Regulatory)
United
States
Securities
and Exchange Commission
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15[d] of the Securities Exchange Act of 1934
January
17, 2020
Date
of Report
Q2EARTH,
INC.
(Exact
name of Registrant as specified in its Charter)
|
Delaware
|
|
000-55148
|
|
20-1602779
|
|
(State
or Other Jurisdiction
of
Incorporation)
|
|
(Commission
File
Number)
|
|
(I.R.S.
Employer
Identification
No.)
|
420
Royal Palm Way, #100
Palm
beach, FL 33480
(Address
of Principal Executive Offices)
(561)
693-1423
(Registrant’s
Telephone Number, including area code)
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions (see general instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14-a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
|
Title
of Each Class
|
|
Trading
Symbol(s)
|
|
Name
of Each Exchanged on Which Registered
|
|
Common
Stock
|
|
QPWR
|
|
OTCQB
|
|
Item 5.02
|
Election of Director; Departure of Certain Officers; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.
|
On
January 16, 2020, the Board of Directors of Q2Earth, Inc. (“Q2Earth” or the “Company”) appointed
Douglas R. Baum as a director of Q2Earth, effective immediately. Mr. Baum currently serves as a consultant to several drug development
companies. From 2011 to January 2017 he served as President and CEO at Xeris Pharmaceuticals overseeing production of approvals
through the FDA and capital raising.
Other
than his appointment to the Q2Earth board during the past 5 years, Mr. Baum has not served on the board of directors of any company
that was required to file reports pursuant to the Securities Exchange Act of 1934, as amended, or was a registered investment
company under the Investment Company Act of 1940, as amended. Mr. Baum was granted a 5-year option to purchase 200,000 shares
of the Company’s commons stock exercisable at $0.02 per share. The options vest one-half in 12 months and the balance in
24 months.
The
Company issued a Press Release announcing the appointment of Mr. Baum, copy of which is attached as Exhibit 99.1 and is incorporated
by reference
|
Item 9.01
|
Financial Statements Pro Forma Financial Information and Exhibits.
|
SIGNATURES
Pursuant
to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Current Report to be signed
on its behalf by the undersigned hereunto duly authorized.
|
|
Q2EARTH INC.
|
|
|
|
|
|
Date: January 17, 2020
|
By:
|
/s/ Kevin
Bolin
|
|
|
|
Kevin Bolin
|
|
|
|
Chief Executive Officer
|